August 2025 AMR CoP ECHO session: AMR Surveillance and Data Utilization for Healthcare
15 August 2025 In this session, Dr. Lillian Musila explores how AMR surveillance data can be transformed into actionable insights for clinical care, public health, and policy. She
Tackling Antimicrobial Resistance: A call to action from the UNGA High-Level Meeting
The article from The Star highlights the grave threat of Antimicrobial Resistance (AMR), particularly in Africa where health systems are already strained. It emphasizes that while
July 2025 LabCoP Extended ECHO Session: Practical Approaches to tNGS Implementation for Rapid Detection of Drug-Resistant TB: Insights from West Java, Indonesia
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
Lab Lessons from the Frontlines: April–June 2025 in Review
Between April and June 2025, the Laboratory Systems Strengthening Community of Practice (LabCoP), with support from the Gates Foundation and partner organizations, convened ten imp
July 2025 AMR CoP ECHO Session: Success Stories and Challenges in Implementing Infection Prevention and Control (IPC) in Resource-Limited Settings
As we continue to confront the growing threat of antimicrobial resistance, Infection Prevention and Control (IPC) remains one of the most powerful and cost-effective interventions
June 2025 AMR CoP ECHO Session: Simplifying AMR Surveillance by Building Expertise Alongside Automated AMR/C/U Analysis through Africa’s Knowledge
This AMR CoP ECHO session focuses on simplifying AMR surveillance by building expertise alongside automated AMR/C/U analysis through Africa’s Knowledge Hub. This session demonstr
June 2025 LabCoP Extended ECHO Session: Flying blind: the urgent need for rapid detection of bedaquiline-resistant TB
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
May 2025 LabCoP Extended Echo Session. Closing the gap in drug-resistant TB diagnosis: the critical role of sequencing
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
Reaching the End TB Goals: The Role of Strong Diagnostic Networks
Each year on March 24th, World TB Day serves as an important reminder that tuberculosis (TB) remains a significant public health challenge. Despite being an ancient disease, TB con
October 2024 AMR CoP ECHO Session: The EUCAST system and EUCAST clinical breakpoints
In this Antimicrobial (AMR) Community of Practice (CoP) webinar on 11 October 2024, we focus on the European Committee on Antimicrobial Susceptibility Testing (EUCAST), tracing its